The endothelium: barrier, anticoagulant, NO and Weibel–Palade bodies
- Cell
One layer of cells lines every vessel, and it decides whether blood flows, clots or leaks. Most heart attacks and strokes begin with it failing.
What it is
Endothelium is the simple squamous epithelium lining the heart, blood vessels and lymphatics. Besides acting as a selective barrier, it keeps blood from clotting on healthy surfaces, makes vasodilators and vasoconstrictors, controls the exit of leukocytes, and sprouts new vessels. When injured or activated it switches to a pro-thrombotic, pro-inflammatory state, the starting point of atherosclerosis and thrombosis.
Structure
- Flat, elongated cells aligned with the flow, joined by tight and adherens junctions (VE-cadherin), on a basal lamina.
- Weibel–Palade bodies: rod-shaped granules that store von Willebrand factor (vWF) and P-selectin, released within minutes of activation.
- Luminal glycocalyx with heparan sulfate, which binds and activates antithrombin.
- Caveolae and transcytotic vesicles carry substances across the cell.
Step by step
- Healthy surface: NO and prostacyclin keep platelets quiet and muscle relaxed; heparan sulfate and thrombomodulin hold clotting back.
- Injury or activation (trauma, cytokines, shear loss, smoking, LDL) flips the cell to its pro-thrombotic side.
- Weibel–Palade bodies release vWF, which binds exposed collagen and catches platelets via GPIb.
- Tissue factor is exposed or expressed and starts the coagulation cascade.
- P-selectin and E-selectin appear on the surface and leukocytes start to roll; endothelin narrows the vessel.
- Chronic, low-grade activation lets LDL and monocytes into the intima: the first step of atherosclerosis.
Resting versus activated endothelium
| Job | Resting (healthy) | Activated or injured |
|---|---|---|
| Clotting | Anticoagulant: heparan sulfate with antithrombin, thrombomodulin activating protein C, tissue factor pathway inhibitor | Pro-coagulant: tissue factor exposed, vWF released |
| Platelets | Inhibited by prostacyclin and nitric oxide | Captured by vWF |
| Fibrinolysis | Tissue plasminogen activator (t-PA) dissolves clots | Plasminogen activator inhibitor (PAI-1) rises |
| Vessel tone | Dilated by nitric oxide and prostacyclin | Constricted by endothelin |
| Leukocytes | Few adhesion molecules: cells flow past | E- and P-selectin, ICAM-1, VCAM-1, chemokines: cells roll, stick and exit |
Markers
- CD31 (PECAM-1)
- CD34
- ERG
- von Willebrand factor
Clinical notes
- Endothelial dysfunction (smoking, hypertension, high LDL, diabetes) lowers nitric oxide and lets lipids and monocytes into the intima: the first step of atherosclerosis.
- Von Willebrand disease: deficient or defective vWF, the bridge between platelets and collagen and the carrier that protects factor VIII.
- Lung capillary endothelium carries much of the angiotensin-converting enzyme (ACE), which also breaks down bradykinin: hence the cough with ACE inhibitors.
- Tumours secrete VEGF to recruit vessels; anti-VEGF drugs are used in some cancers and in retinal disease.
Common traps
- Weibel–Palade bodies hold vWF and tissue factor: they store vWF and P-selectin, the glue for platelets and the first hook for leukocytes.
- vWF comes only from endothelium: megakaryocytes make it too and store it in platelet alpha granules.
- Nitric oxide is stored in endothelial granules: it is a gas made on demand by endothelial NO synthase, so it cannot be stored.
- Factor VIII is low in von Willebrand disease because the liver makes less: vWF carries and protects factor VIII, so without vWF it is broken down faster.
Test yourself
Think of the answer, then tap the question to see it.
A smoker's arteries make less nitric oxide. What are two consequences for the vessel wall?
Platelets are less inhibited and the vessel constricts more; adhesion molecules rise and LDL and monocytes enter the intima, starting atherosclerosis.
Endothelial cells are activated by histamine. Which two molecules reach their surface within minutes, and from where?
Von Willebrand factor and P-selectin, from the Weibel–Palade bodies.
Why does a patient with severe von Willebrand disease also have low factor VIII?
vWF carries and protects factor VIII in plasma; without it, factor VIII is cleared faster.
Which tumour marker panel would you use to show that a malignant tumour is made of endothelial cells?
Endothelial markers such as CD31, ERG and CD34 (and vWF).
Elsewhere in DurgiPedia
Connections
Educational content on normal microscopic structure and its clinical relevance; no substitute for studying slides or for a health professional's advice.
Sources: Classification & Structure of Blood Vessels (National Cancer Institute, SEER Training Modules, 2024); Von Willebrand disease: MedlinePlus Medical Encyclopedia (MedlinePlus, US National Library of Medicine, 2025).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
